Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): John T Saxon , Keith B Allen , David J Cohen , et al Added: 3 years ago
Surgical aortic valve replacement (SAVR) has long been the standard of care for aortic valve replacement. More recently, transcatheter aortic valve replacement (TAVR) has been established as a safe, effective and less invasive method of valve replacement in patients with severe aortic stenosis who are at intermediate or high risk for complications related to SAVR.1–4 For patients who present with… View more
Author(s): Santiago Garcia Added: 1 year ago
TCT 22 - Dr Santiago Garcia (Minneapolis Heart Institute at Abbott Northwestern Hospital, MN, US) joins us to discuss the findings of a substudy of the PARTNER 3 Trial which aimed to evaluate the safety and efficacy of Edwards' SAPIEN 3 Ultra transcatheter heart valve in aortic stenosis patients with a failing bioprosthetic valve. In this study, 125 patients received TAVR using the Sapien 3… View more
Author(s): John Phineas O’Donnell , Crochan J O’Sullivan Added: 3 years ago
The demand for replacing degenerated bioprosthetic valves (BPVs) is steadily rising owing to the increasing burden of heart disease, ageing populations, advances in surgical intervention and limited durability of current-generation surgical BPVs. The issue is exacerbated by the increasing trend of surgical BPV replacement, especially in younger patients who are likely to require future… View more
Author(s): Lars Søndergaard , Hendrik Treede Added: 3 years ago
In this video, you will understand the long-term outcome of the randomized NOTION trial comparing TAVI and SAVR in low risk patients. LEARNING OBJECTIVES Appreciate how supra-annular valve position can impact on long-term valve durability Recognise the importance of transvalvular gradients and opening area on valve performance and structural valve deterioration Understand the difference… View more
Author(s): Martin B Leon Added: 5 months ago
TCT 23 - In this short virtual interview, we are joined by Dr Martin B Leon (Columbia University Medical Center, US) to discuss the 5-year outcomes from Edwards' PARTNER 3 low-risk trial (NCT02675114).PARTNER 3 is a randomized, prospective, multicenter trial that aimed to determine the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with severe calcific aortic… View more
Author(s): Giuliano Costa , Enrico Criscione , Denise Todaro , et al Added: 3 years ago
Aortic stenosis (AS) is one of the most common valvular diseases in developed countries and its prevalence is projected to increase over the next decade as the population ages.1,2 Transcatheter aortic valve implantation (TAVI) is an established alternative to surgery for treatment of patients with symptomatic, severe AS.3 As the latest multicentre trials have established the role of TAVI… View more
Author(s): Ren Jie Yao , Matheus Simonato , Danny Dvir Added: 3 years ago
In the context of an ageing population, care for valvular disease is becoming an increasingly important field. A recent large-scale population-based study found the prevalence of valvular disease to be 8.5 % in the 65–74-year-old group and 13.2 % in those over 75 years. 1 While mechanical surgical valves are more durable, bioprosthetic valves are often used as they are less thrombogenic and do… View more
Foreword

Article

Author(s): Simon Kennon Added: 3 years ago
This year’s final issue of Interventional Cardiology Review contains a superb section on the assessment and treatment of calcified coronary artery disease. Five articles commissioned by guest editor Nicolas Van Mieghem cover ‘all you need to know but were too scared to ask’ about this ever-relevant subject. The rest of the issue is evenly split between structural and coronary papers offering, as… View more
Author(s): Fadi J Sawaya , Lars Søndergaard Added: 3 years ago
Over the past decade, transcatheter aortic valve implantation (TAVI) has become an established and increasingly-used technique to treat patients with severe aortic valve stenosis (AS). Studies have revealed that clinical outcomes obtained with TAVI are equivalent to surgical aortic valve replacement (SAVR) in patients with a high risk profile.1,2 The Placement of Aortic Transcatheter Valves … View more